September 10, 2020 - An investigation on behalf of investors of Livongo Health, Inc. (NASDAQ: LVGO) shares over potential securities laws violations by Livongo Health, Inc. and certain of its directors and officers in connection with certain financial statements was announced.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Livongo Health, Inc. (NASDAQ: LVGO) concerning whether a series of statements by Livongo Health, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Mountain View, CA based Livongo Health, Inc. provides an integrated suite of solutions for the healthcare industry in North America. On July 24, 2019, Livongo Health, Inc announced the pricing of its initial public offering (IPO) of approximately 12.7 million shares at $28.00 per share. Livongo Health, Inc raised $355.60 million in its IPO.

Since, the IPO shares of Livongo Health, Inc. (NASDAQ: LVGO) declined to as low as $15.12 per share on October 2, 2019.